Bjarke Risgaard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bjarke Risgaard has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Jacob Tfelt-Hansen
The Heart Centre, Copenhagen University Hospital, Rigshospitalet, and Department of Medicine and Surgery, University of Copenhagen, Copenhagen
14 shared publications - Bo Gregers Winkel
Department of Cardiology, The Heart Centre, Copenhagen University Hospital - Rigshospitalet , Copenhagen 2100
12 shared publications Reza Jabbari
The Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
5 shared publications- Reza Jabbari
Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark (J.M.M., C.G., R.J., M. Sabbah, L.H., R.S., G.B., T.H.J., O.D.B., T.E., J.L.).
5 shared publications Stig Haunsø
The Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Department of Medicine and Surgery, University of Copenhagen, Copenhagen, Denmark
5 shared publicationsCharlotte Glinge
The Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
4 shared publications
Latest Publications
- Open Access
- 2 September 2025
- Published by Elsevier in Resuscitation Plus
- Vol. 26, 101084
Impact of extended eligibility criteria on survival after veno-arterial extracorporeal membrane oxygenation for refractory cardiac arrest: a 8-year single-center study
- 2 September 2025
- Published by Elsevier in Resuscitation Plus
- Vol. 26, 101084
Open AccessImpact of extended eligibility criteria on survival after veno-arterial extracorporeal membrane oxygenation for refractory cardiac arrest: a 8-year single-center study
- Open Access
- 17 January 2020
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 64 (5) , 691-704
Impact of Physician‐staffed Helicopters on Pre‐hospital Patient Outcomes: A systematic review
Background: Management of pre‐hospital patients remains a challenge. In developed countries a physician‐staffed helicopter emergency medical service (PS‐HEMS) is used in addition to ground emergency medical service (GEMS), but the effect is debated. This systematic review aimed to evaluate the effect of PS‐HEMS compared with GEMS on patient outcomes based on the published scientific literature.Methods: Medline, EMBASE and the Cochrane Library were systematically searched on November 15, 2019 for prospective, interventional studies comparing outcomes of patients transported by either PS‐HEMS or GEMS. Outcomes of interest were mortality, time to hospital and quality of life.Results: The majority of 18 studies included were observational and difficult to summarize because of heterogeneity. Meta‐analysis could not be carried out. Three studies found reduced mortality in patients transported by PS‐HEMS compared with GEMS with Odds ratios (OR) of 0.68 (0.47‐0.98); 0.29 (0.10‐0.82) and 0.21 (0.06‐0.73) respectively. Another two studies found improved survival with OR 1.2 (1.0‐1.5) and 6.9 (1.48‐32.5) in patients transported by PS‐HEMS compared with GEMS. In three studies, PS‐HEMS was associated with shorter time to hospital. Three studies reported quality of life and found no benefit of PS‐HEMS.Conclusion: In this systematic review the studies comparing PS‐HEMS with GEMS were difficult to summarize because of heterogeneity. We found a possible survival benefit of PS‐HEMS but were unable to conduct a meta‐analysis. The overall quality of evidence was low.
- 17 January 2020
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 64 (5) , 691-704
Open AccessImpact of Physician‐staffed Helicopters on Pre‐hospital Patient Outcomes: A systematic review
Background: Management of pre‐hospital patients remains a challenge. In developed countries a physician‐staffed helicopter emergency medical service (PS‐HEMS) is used in addition to ground emergency medical service (GEMS), but the effect is debated. This systematic review aimed to evaluate the effect of PS‐HEMS compared with GEMS on patient outcomes based on the published scientific literature.Methods: Medline, EMBASE and the Cochrane Library were systematically searched on November 15, 2019 for prospective, interventional studies comparing outcomes of patients transported by either PS‐HEMS or GEMS. Outcomes of interest were mortality, time to hospital and quality of life.Results: The majority of 18 studies included were observational and difficult to summarize because of heterogeneity. Meta‐analysis could not be carried out. Three studies found reduced mortality in patients transported by PS‐HEMS compared with GEMS with Odds ratios (OR) of 0.68 (0.47‐0.98); 0.29 (0.10‐0.82) and 0.21 (0.06‐0.73) respectively. Another two studies found improved survival with OR 1.2 (1.0‐1.5) and 6.9 (1.48‐32.5) in patients transported by PS‐HEMS compared with GEMS. In three studies, PS‐HEMS was associated with shorter time to hospital. Three studies reported quality of life and found no benefit of PS‐HEMS.Conclusion: In this systematic review the studies comparing PS‐HEMS with GEMS were difficult to summarize because of heterogeneity. We found a possible survival benefit of PS‐HEMS but were unable to conduct a meta‐analysis. The overall quality of evidence was low.
- Open Access
- 21 November 2017
- Published by Springer Nature in BMC Medical Genetics
- Vol. 18 (1) , 138
Association of common genetic variants related to atrial fibrillation and the risk of ventricular fibrillation in the setting of first ST-elevation myocardial infarction
Cohort studies have revealed an increased risk for ventricular fibrillation (VF) and sudden cardiac death (SCD) in patients with atrial fibrillation (AF). In this study, we hypothesized that single nucleotide polymorphisms (SNP) previously associated with AF may be associated with the risk of VF caused by first ST-segment elevation myocardial infarction (STEMI). We investigated association of 24 AF-associated SNPs with VF in the prospectively assembled case–control study among first STEMI-patients of Danish ancestry. We included 257 cases (STEMI with VF) and 537 controls (STEMI without VF). The median age at index infarction was 60 years for the cases and 61 years for the controls (p = 0.100). Compared to the control group, the case group was more likely to be male (86% vs. 75%, p = 0.001), have a history of AF (7% vs. 2%, p = 0.006) or hypercholesterolemia (39% vs. 31%, p = 0.023), and a family history of sudden death (40% vs. 25%, p < 0.001). All 24 selected SNPs have previously been associated with AF. None of the 24 SNPs were associated with the risk of VF after adjustment for age and sex under additive genetic model of inheritance in the logistic regression model. In this study, we found that the 24 AF-associated SNPs may not be involved in increasing the risk of VF. Larger VF cohorts and use of new next generation sequencing and epigenetic may in future identify additional AF and VF risk loci and improve our understanding of genetic pathways behind the two arrhythmias.
- 21 November 2017
- Published by Springer Nature in BMC Medical Genetics
- Vol. 18 (1) , 138
Open AccessAssociation of common genetic variants related to atrial fibrillation and the risk of ventricular fibrillation in the setting of first ST-elevation myocardial infarction
Cohort studies have revealed an increased risk for ventricular fibrillation (VF) and sudden cardiac death (SCD) in patients with atrial fibrillation (AF). In this study, we hypothesized that single nucleotide polymorphisms (SNP) previously associated with AF may be associated with the risk of VF caused by first ST-segment elevation myocardial infarction (STEMI). We investigated association of 24 AF-associated SNPs with VF in the prospectively assembled case–control study among first STEMI-patients of Danish ancestry. We included 257 cases (STEMI with VF) and 537 controls (STEMI without VF). The median age at index infarction was 60 years for the cases and 61 years for the controls (p = 0.100). Compared to the control group, the case group was more likely to be male (86% vs. 75%, p = 0.001), have a history of AF (7% vs. 2%, p = 0.006) or hypercholesterolemia (39% vs. 31%, p = 0.023), and a family history of sudden death (40% vs. 25%, p < 0.001). All 24 selected SNPs have previously been associated with AF. None of the 24 SNPs were associated with the risk of VF after adjustment for age and sex under additive genetic model of inheritance in the logistic regression model. In this study, we found that the 24 AF-associated SNPs may not be involved in increasing the risk of VF. Larger VF cohorts and use of new next generation sequencing and epigenetic may in future identify additional AF and VF risk loci and improve our understanding of genetic pathways behind the two arrhythmias.
- 1 May 2017
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 3 (5) , 473-481
Sudden Cardiac Death
- 1 May 2017
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 3 (5) , 473-481
Sudden Cardiac Death
- 1 December 2016
- Vol. 63 (12)
Sudden cardiac death: A nationwide cohort study among the young
Sudden cardiac death (SCD) is a tragic event affecting millions of individuals worldwide. Although several studies have investigated the epidemiology of SCD, these studies may have been affected by reporting and referral biases, which are reflected in the very different incidence rates and causes of deaths that have previously been reported. Among SCD victims aged < 36 years, inherited cardiac diseases are well known to play an important role. However, the extent to which inherited cardiac diseases also play a role in SCD victims aged < 50 years has not been completely described. Additionally, SCD in children is of particular interest. These deaths are often described as a part of the deaths of young adolescents up to 40 years of age, and the focus has recently shifted towards the prevention of these deaths. The SCD incidence rate among patients with psychiatric disease has also gained significant attention. Finally, the incidence rate of sports-related sudden cardiac death (SrSCD) has been thoroughly investigated in young competitive athletes. However, whether competitive athletes are at increased risk for SrSCD compared with non-competitive athletes remains unknown. These data should be available prior to discussing optimal screening strategies for (competitive) athletes. In this thesis, we investigated the SCD burden in Danes aged 1-49 years between 2007 and 2009. By using the unique Danish death certificates, autopsy reports, discharge summaries, and registries, we included all deaths in a nationwide setting. We described the incidence rates and causes of death, and we performed a sub-group analysis of SCD in children (1-18 years, 2000-2006). Furthermore, we described the SCD burden in competitive and non-competitive athletes and investigated how often SCD occurred in patients with previous psychiatric disease. SCD has an incidence rate of 8.6 (95% confidence interval (CI) 8.0-9.2) per 100,000 person-years in persons aged 1-49 years. We found a steep increase in the incidence rate with increasing age, reaching 38.5 (95% CI 32.9-44.7) per 100,000 person-years in persons aged 48-49 years. The most common causes of death were coronary artery disease (CAD) (n = 158) and sudden unexplained death (SUD) (n = 136). In the 1-35-year age group, SUD was significantly more common than CAD. In contrast, CAD was significantly more common than SUD in the 36-49-year age group. In children 1-18 years of age, SCD is a seemingly rare occurrence with an incidence rate of only 1.1 (95% CI 0.9-1.3) deaths per 100,000 person-years. Similarly to the 1-35-year age group, SUD is often the cause of death in children. Overall, 49% of all SCDs in children are caused by a potentially inherited cardiac disease, emphasizing the need for autopsy as well as for follow-up and genetic testing of the affected family members. In Denmark, SrSCD is a very rare occurrence. The SrSCD incidence rate increases with increasing age but remains much lower than the SCD incidence rate in the general population. Importantly, we found no differences in the incidence rate between competitive and non-competitive athletes aged 12-35 years (incidence rate ratio 1.1; 95% CI 0.2-5.1, p = 0.88) and 36-49 years (incidence rate ratio 2.2; 95% CI 0.9-5.1, p = 0.06). These results add important knowledge to the ongoing debate regarding whether mandatory screening programs with electrocardiograms should be recommended for young competitive athletes, as suggested by the European Society of Cardiology. The current results suggest that screening only competitive athletes would be ethically questionable because non-competitive athletes are at the same risk for SrSCD. Patients with psychiatric disease are known to have an increased cardiovascular risk. For the first time, we describe the nationwide SCD incidence rates of SCD as well as the causes of death in patients with previous psychiatric disease. We reported an SCD incidence rate ratio of 4.3 (95% CI 3.3-5.5: p < 0.01) in patients with previous psychiatric disease compared with patients without psychiatric disease. The higher incidence rate is largely driven by schizophrenia-spectrum and substance-related disorders. Interestingly, SUD is more common among patients with psychiatric diseases, suggesting that many of these deaths are triggered by medications that caused a primary arrhythmic event. Future research should investigate the extent to which CAD among individuals younger than 50 years of age is caused by inherited cardiac conditions such as familial hypercholesterolemia. The extent to which medication use prior to death may contribute to SCD and SUD should also be evaluated. Finally, with the availability of dried blood spot samples from all infants in Denmark, future research should also investigate the genetic substrate of SCD and SUD.
- 1 December 2016
- Vol. 63 (12)
Sudden cardiac death: A nationwide cohort study among the young
Sudden cardiac death (SCD) is a tragic event affecting millions of individuals worldwide. Although several studies have investigated the epidemiology of SCD, these studies may have been affected by reporting and referral biases, which are reflected in the very different incidence rates and causes of deaths that have previously been reported. Among SCD victims aged < 36 years, inherited cardiac diseases are well known to play an important role. However, the extent to which inherited cardiac diseases also play a role in SCD victims aged < 50 years has not been completely described. Additionally, SCD in children is of particular interest. These deaths are often described as a part of the deaths of young adolescents up to 40 years of age, and the focus has recently shifted towards the prevention of these deaths. The SCD incidence rate among patients with psychiatric disease has also gained significant attention. Finally, the incidence rate of sports-related sudden cardiac death (SrSCD) has been thoroughly investigated in young competitive athletes. However, whether competitive athletes are at increased risk for SrSCD compared with non-competitive athletes remains unknown. These data should be available prior to discussing optimal screening strategies for (competitive) athletes. In this thesis, we investigated the SCD burden in Danes aged 1-49 years between 2007 and 2009. By using the unique Danish death certificates, autopsy reports, discharge summaries, and registries, we included all deaths in a nationwide setting. We described the incidence rates and causes of death, and we performed a sub-group analysis of SCD in children (1-18 years, 2000-2006). Furthermore, we described the SCD burden in competitive and non-competitive athletes and investigated how often SCD occurred in patients with previous psychiatric disease. SCD has an incidence rate of 8.6 (95% confidence interval (CI) 8.0-9.2) per 100,000 person-years in persons aged 1-49 years. We found a steep increase in the incidence rate with increasing age, reaching 38.5 (95% CI 32.9-44.7) per 100,000 person-years in persons aged 48-49 years. The most common causes of death were coronary artery disease (CAD) (n = 158) and sudden unexplained death (SUD) (n = 136). In the 1-35-year age group, SUD was significantly more common than CAD. In contrast, CAD was significantly more common than SUD in the 36-49-year age group. In children 1-18 years of age, SCD is a seemingly rare occurrence with an incidence rate of only 1.1 (95% CI 0.9-1.3) deaths per 100,000 person-years. Similarly to the 1-35-year age group, SUD is often the cause of death in children. Overall, 49% of all SCDs in children are caused by a potentially inherited cardiac disease, emphasizing the need for autopsy as well as for follow-up and genetic testing of the affected family members. In Denmark, SrSCD is a very rare occurrence. The SrSCD incidence rate increases with increasing age but remains much lower than the SCD incidence rate in the general population. Importantly, we found no differences in the incidence rate between competitive and non-competitive athletes aged 12-35 years (incidence rate ratio 1.1; 95% CI 0.2-5.1, p = 0.88) and 36-49 years (incidence rate ratio 2.2; 95% CI 0.9-5.1, p = 0.06). These results add important knowledge to the ongoing debate regarding whether mandatory screening programs with electrocardiograms should be recommended for young competitive athletes, as suggested by the European Society of Cardiology. The current results suggest that screening only competitive athletes would be ethically questionable because non-competitive athletes are at the same risk for SrSCD. Patients with psychiatric disease are known to have an increased cardiovascular risk. For the first time, we describe the nationwide SCD incidence rates of SCD as well as the causes of death in patients with previous psychiatric disease. We reported an SCD incidence rate ratio of 4.3 (95% CI 3.3-5.5: p < 0.01) in patients with previous psychiatric disease compared with patients without psychiatric disease. The higher incidence rate is largely driven by schizophrenia-spectrum and substance-related disorders. Interestingly, SUD is more common among patients with psychiatric diseases, suggesting that many of these deaths are triggered by medications that caused a primary arrhythmic event. Future research should investigate the extent to which CAD among individuals younger than 50 years of age is caused by inherited cardiac conditions such as familial hypercholesterolemia. The extent to which medication use prior to death may contribute to SCD and SUD should also be evaluated. Finally, with the availability of dried blood spot samples from all infants in Denmark, future research should also investigate the genetic substrate of SCD and SUD.
- 1 July 2016
- Published by Elsevier in Heart Rhythm
- Vol. 13 (7) , 1560-1562
Sports-related sudden cardiac death: How to prove an effect of preparticipation screening?
- 1 July 2016
- Published by Elsevier in Heart Rhythm
- Vol. 13 (7) , 1560-1562
Sports-related sudden cardiac death: How to prove an effect of preparticipation screening?
- 23 September 2015
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 76 (09) , e1122-e1129
Sudden Cardiac Death in Young Adults With Previous Hospital-Based Psychiatric Inpatient and Outpatient Treatment
From The Journal of Clinical Psychiatry:
- 23 September 2015
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 76 (09) , e1122-e1129
Sudden Cardiac Death in Young Adults With Previous Hospital-Based Psychiatric Inpatient and Outpatient Treatment
From The Journal of Clinical Psychiatry:
- 1 May 2015
- Published by Elsevier in Heart Rhythm
- Vol. 12 (5) , 968-974
Risk factors and causes of sudden noncardiac death: A nationwide cohort study in Denmark
- 1 May 2015
- Published by Elsevier in Heart Rhythm
- Vol. 12 (5) , 968-974
Risk factors and causes of sudden noncardiac death: A nationwide cohort study in Denmark
- Open Access
- 14 April 2015
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 15 (1) , 1-8
Sudden death in young persons with uncontrolled asthma - a nationwide cohort study in Denmark
Asthma is a common chronic disease among young adults, and several studies have reported increased mortality rates in patients with asthma. However, no study has described sudden unexpected death in a nationwide setting in patients with uncontrolled asthma. We defined uncontrolled asthma as a previous hospital admittance because of asthma (of any severity) or when asthma was considered to have influenced the death according to the death certificate. The purpose of this study is to increase the medical focus on young persons with uncontrolled asthma and thereby hopefully aid in preventing sudden unexpected deaths. We therefore aimed to describe clinical characteristics, symptoms, causes of death, and contact with the healthcare system prior to sudden unexpected death in young persons with uncontrolled asthma. Through the review of death certificates, we found 625 sudden unexpected death cases in individuals aged 1–35 years in Denmark from 2000 to 2006. Of those, 49 persons with uncontrolled asthma were identified. Previous contacts with the healthcare system were identified, and available records from general practitioners were retrieved. We identified 49 individuals who suffered from uncontrolled asthma. This corresponds to an incidence rate of 0.32 per 100,000 person-years. The cause of death in 31 cases (63%) was sudden cardiac death, and in 13 cases (27%), it was a fatal asthma attack. Symptoms (chest pain, dyspnea, seizures, general malaise, syncope, and palpitations) prior to death were reported in 41 (84%) of the cases. In 34 (69%) of the cases, antecedent symptoms (symptoms >24 hours before death) were present, and 28 (57%) patients had prodromal symptoms (symptoms <24 hours before death). The most common antecedent symptoms were dyspnea and chest pain, whereas the most common prodromal symptoms were dyspnea, general malaise, and/or fatigue. Twenty-eight patients (57%) sought medical advice from a general practitioner and/or emergency department due to these symptoms. The cause of death was predominantly sudden cardiac death followed by fatal asthma attack. We found that 41 (84%) of patients suffered from symptoms prior to death and that 28 (57%) sought medical advice from the emergency department and/or general practitioners.
- 14 April 2015
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 15 (1) , 1-8
Open AccessSudden death in young persons with uncontrolled asthma - a nationwide cohort study in Denmark
Asthma is a common chronic disease among young adults, and several studies have reported increased mortality rates in patients with asthma. However, no study has described sudden unexpected death in a nationwide setting in patients with uncontrolled asthma. We defined uncontrolled asthma as a previous hospital admittance because of asthma (of any severity) or when asthma was considered to have influenced the death according to the death certificate. The purpose of this study is to increase the medical focus on young persons with uncontrolled asthma and thereby hopefully aid in preventing sudden unexpected deaths. We therefore aimed to describe clinical characteristics, symptoms, causes of death, and contact with the healthcare system prior to sudden unexpected death in young persons with uncontrolled asthma. Through the review of death certificates, we found 625 sudden unexpected death cases in individuals aged 1–35 years in Denmark from 2000 to 2006. Of those, 49 persons with uncontrolled asthma were identified. Previous contacts with the healthcare system were identified, and available records from general practitioners were retrieved. We identified 49 individuals who suffered from uncontrolled asthma. This corresponds to an incidence rate of 0.32 per 100,000 person-years. The cause of death in 31 cases (63%) was sudden cardiac death, and in 13 cases (27%), it was a fatal asthma attack. Symptoms (chest pain, dyspnea, seizures, general malaise, syncope, and palpitations) prior to death were reported in 41 (84%) of the cases. In 34 (69%) of the cases, antecedent symptoms (symptoms >24 hours before death) were present, and 28 (57%) patients had prodromal symptoms (symptoms <24 hours before death). The most common antecedent symptoms were dyspnea and chest pain, whereas the most common prodromal symptoms were dyspnea, general malaise, and/or fatigue. Twenty-eight patients (57%) sought medical advice from a general practitioner and/or emergency department due to these symptoms. The cause of death was predominantly sudden cardiac death followed by fatal asthma attack. We found that 41 (84%) of patients suffered from symptoms prior to death and that 28 (57%) sought medical advice from the emergency department and/or general practitioners.
- 7 March 2015
- Published by Elsevier in Heart Rhythm
- Vol. 12 (6) , 1241-1249
The role of the sodium current complex in a nonreferred nationwide cohort of sudden infant death syndrome
- 7 March 2015
- Published by Elsevier in Heart Rhythm
- Vol. 12 (6) , 1241-1249
The role of the sodium current complex in a nonreferred nationwide cohort of sudden infant death syndrome